ARTICLE | Company News
TCR2 to manufacture T cell therapies at CGT Catapult
March 29, 2019 6:46 PM UTC
TCR2 will work with Cell and Gene Therapy Catapult (London, U.K.) to manufacture the biotech's TCR Fusion Construct T cells therapies...
BCIQ Company Profiles